PROVe Study: How Long Are Patients On Therapy? #EORTC2019

PROVe Study: How Long Are Patients On Therapy? #EORTC2019

Cancer-News

1 week
11 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Ellen J. Kim, MD of @PennMedicine addresses questions asked by colleagues including: how long are patients on therapy in the PROVe Study? #EORTC19

_______

Dr. Ellen J. Kim, UPENN, Professor of Dermatology, Penn Cutaneous Lymphoma Program, PROVe principal investigator, said: “The rarity of MF-CTCL has resulted in there being limited knowledge available for those affected by this disease, as well as many clinicians. We are pleased to have conducted the PROVe study and to further highlight our findings at the EORTC, as we set out to further expand our knowledge concerning the field of MF and current treatment options. The observational study assessed nearly 300 patients and verified that continued treatment of MF-CTCL patients with chlormethine gel is important and associated with improved patients' health-related quality of life.”

Up Next Autoplay
When Can This Be Used In Clinical Practice?
When Can This Be Used In Clinical Practice?
Category: Other
1 Views
Baylor College of Medicine 1 day
New Testing for Thyroid Cancer
New Testing for Thyroid Cancer
Category: Other
3 Views
Baylor College of Medicine 1 day
Lower Costs for Patients in Metastatic Breast Cancer
Lower Costs for Patients in Metastatic Breast Cancer
Category: Breast Cancer
10 Views
ONeal Comprehensive Cancer Center 3 days
New Technology to Streamline Drug Discovery
New Technology to Streamline Drug Discovery
Category: Other
4 Views
Cancer-News 4 days
Using Technology to Better Understand What Goes Wrong in Cancer
Using Technology to Better Understand What Goes Wrong in Cancer
Category: Breast Cancer
11 Views
Cancer-News 4 days
How Does This Affect Clinicians Today?
How Does This Affect Clinicians Today?
Category: Breast Cancer
4 Views
Cancer-News 4 days
Measuring Chromatin Accessibility: How Reliable is This Data?
Measuring Chromatin Accessibility: How Reliable is This Data?
Category: Breast Cancer
8 Views
Cancer-News 4 days
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Category: Melanoma and Skin Cancer
9 Views
Cancer-News 4 days
Mapping the usual breast development to recognize cancer better
Mapping the usual breast development to recognize cancer better
Category: Breast Cancer
11 Views
Cancer-News 4 days
Metformin: How Does This Affect Treatment?
Metformin: How Does This Affect Treatment?
Category: Ovarian Cancer
10 Views
Cancer-News 4 days